Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
1,274 total articles
Cue Biopharma announced a CEO transition with Lucinda Warren stepping in as interim president and CEO following Usman Azam's departure. Warren brings over 30 years of pharmaceutical and biotech experience and has been instrumental in securing key deals for the company. The firm plans to advance its lead autoimmune therapy, CUE-401, into clinical tr…
Presurance Holdings reported its financial results for Q4 and full year 2025, showing a deliberate exit from commercial lines with zero premium from that segment in Q4 and a 12.7% increase in personal lines production. The company continues to face significant adverse developments from prior commercial lines business, resulting in large net losses …
Editas Medicine announced that the U.S. Patent and Trademark Office has reaffirmed the Patent Trial and Appeal Board's prior decision recognizing the Broad Institute as the first inventor of CRISPR/Cas9 gene editing technology in human cells. This ruling secures critical intellectual property rights exclusively licensed to Editas for developing and…
ADMA Biologics issued a statement refuting allegations made by short seller Culper Research concerning competitive positioning, inventory management, and accounting practices. The company emphasized steady growth in demand and utilization of its ASCENIV immune globulin product over the past two years, inventory levels aligned with industry standard…
Instil Bio, Inc. disclosed its financial results for Q4 and full-year 2025, reporting a net loss but maintaining a strong cash position of $76.3 million expected to fund operations beyond 2027. The company discontinued clinical development of AXN-2510 via its subsidiary Axion Bio and is now focusing on strategic growth through potential acquisition…
BiomX Inc. received a notice from NYSE American indicating non-compliance with continued listing standards due to insufficient stockholders' equity amid repeated losses. The company must submit a plan to regain compliance by September 2027 or face potential delisting. Additionally, an audit included a going concern qualification, raising financial …
Sotherly Hotels Inc. announced its Board of Directors' decision to voluntarily delist its Preferred Stock from Nasdaq and transition the shares to the OTC Market following a recent merger. Despite the change, Sotherly will maintain its status as a real estate investment trust and continue SEC reporting. The move follows a merger where the majority …
Calidi Biotherapeutics announced key operational milestones including partnering with Avance Clinical to accelerate CLD-401 clinical trial initiation in Australia and Matica Bio for GMP manufacturing. The company received supportive feedback from the FDA on its IND filing plans for CLD-401 expected by end of 2026, presented promising data on in sit…
Aqua Metals, a pioneer in battery metals recycling using AquaRefining technology, will announce its financial results for Q4 and full-year 2025 on March 31, 2026, along with a business update and an investor conference call.
Auddia Inc. will execute a 1-for-7.7 reverse stock split effective April 1, 2026, aiming to increase its stock price above the $1.00 minimum bid price requirement of Nasdaq and maintain its listing. The reverse split will adjust outstanding shares, preferred stock, warrants, stock options, and restricted stock units proportionally without changing …
Crescent Biopharma announced the grant of stock options to three new non-executive employees as inducement awards to facilitate their employment. The options total 35,325 shares with a 10-year term and an exercise price set at the closing market price of $13.50 per share. Vesting occurs over four years, incentivizing employee retention. Crescent is…
Precision Optics Corporation, a leading medical and defense/aerospace optical instruments manufacturer, announced the pricing of an upsized $10 million public offering of 2,777,777 shares at $3.60 per share. The oversubscribed offering attracted institutional investors and participation by company executives. Proceeds will be used for working capit…
Super League Enterprise, Inc. reported its fourth quarter and full year 2025 financial results, highlighting its strongest revenue quarter of the year, improved pro forma EBITDA by 31% year-over-year, and a debt-free balance sheet with $14 million cash. The company has diversified revenue streams, reduced operating costs, expanded gross margin to 4…
LM Funding America, Inc. reported Q4 2025 revenue of $2.4 million, up 8.7% sequentially and 19.2% year-over-year due to higher Bitcoin mining output, producing 22.0 Bitcoin. Despite increased production and expanded operations, the company posted a net loss of $17.9 million, driven by lower Bitcoin prices, impairment on mining equipment, and increa…
Total Return Securities Fund (NYSE: SWZ) has announced that its 2026 Annual Meeting of Stockholders will be held on June 11, 2026, at its Bulldog Investors LLP office. Stockholder proposals and director nominations must be submitted by April 17, 2026, to be considered for the meeting.
Diginex Limited plans an Extraordinary General Meeting to approve an 8-for-1 share consolidation and increase authorized share capital. This move aims to comply with Nasdaq's minimum bid price requirement after receiving a compliance warning due to share price falling below $1. The changes are not expected to materially affect market capitalization…
NIP Group Inc. announced receipt of a Nasdaq Deficiency Letter due to its American Depositary Shares trading below the $1.00 minimum bid price requirement for over 30 consecutive business days. The company has 180 days to regain compliance or potentially face delisting. The notice has no immediate effect on trading, and the company intends to take …
TMC the metals company Inc. announced its fourth quarter and full year 2025 financial results and corporate updates, emphasizing transformative progress in U.S. permitting for commercial deep-sea polymetallic nodule mining, strategic partnerships, and exploration of domestic processing facilities. The company reported a net loss due to increased ad…
CenterPoint Energy, Inc., a leading Texas-based investor-owned electric and gas utility, announced it will host a webcast of its first quarter 2026 earnings conference call on April 23, 2026, providing investors insights into its financial performance and operations.
Brookfield Real Assets Income Fund Inc. declared its monthly distributions for April, May, and June 2026 with a consistent payout of $0.1180 per share each month. Distributions may include net investment income, capital gains, and/or return of capital, with part of the 2026 distributions expected to be treated as return of capital for U.S. tax purp…
Aurora Mobile Limited, a leading Chinese customer engagement and marketing technology company listed on NASDAQ, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025. The report includes audited consolidated financial statements and is available on the company's investor relations website. The company re…
AmpliTech Group announces a conference call to discuss their FY2025 results and provides updates on their expanding 5G product pipeline. The company highlights progress in O-RAN compliant Massive MIMO products, production shipments under existing LOI programs exceeding $20 million, and increased purchase orders indicating the total opportunity may …
Norwegian Cruise Line Holdings Ltd. announced the appointment of five new independent board members, including experienced leaders from diverse industries, and a cooperation agreement with Elliott Investment Management, its largest investor. The board refreshment aims to improve governance and shareholder value, with strengthened leadership under C…
Axe Compute (NASDAQ: AGPU) announced it will release its financial results for the fiscal year ended December 31, 2025 and file its Annual Report on Form 10-K after market close on March 31, 2026. The company will host a conference call and webcast on April 1, 2026, to discuss the financial results, operational progress, and business outlook. Axe C…
AnaptysBio announced a $100 million stock repurchase plan alongside its strategy to spin off its biopharma operations into First Tracks Biotherapeutics by April 20, 2026. Post spin-off, Anaptys will focus on managing financial collaborations related to its partnered assets Jemperli with GSK and imsidolimab with Vanda, operating with a lean structur…
